Genetics of colonic cancer

Digestion

Volumn 59, Issue 5, 1998, Pages 481-492

  Lynch, Henry T ^a   Lynch, Jane F ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attenuated familial adenomatous polyposis; Colorectal cancer; Familial adenomatous polyposis; Familial juvenile polyposis coli; Genetics; Hereditary cancer; Hereditary nonpolyposis colorectal cancer; Lynch syndrome; Molecular genetics; Peutz Jeghers syndrome

Indexed keywords

CANCER SCREENING; CHEMOPROPHYLAXIS; COLON POLYPOSIS; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GERM LINE; HUMAN; MOLECULAR GENETICS; MUTATOR GENE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ADENOMATOUS POLYPOSIS COLI; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CYCLOOXYGENASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; GENES, TUMOR SUPPRESSOR; HUMANS; PEUTZ-JEGHERS SYNDROME; PHENOTYPE;

EID: 0031950025     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007525     Document Type: Review

References (82)

1. Fearon ER: Human cancer syndromes: Clues to the origin and nature of cancer. Science 1997;278:1043-1050.
2. Burt RW: Screening of patients with a positive family history of colorectal cancer. Gastrointest Endosc Clin North Am 1997;7:65-79.
3. Fuchs C, Giovannucci E, Colditz G, Hunter D, Speizer F, Willett W: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-1674.
4. St. John JB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES: Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-790.
5. Lovett E: Family studies in cancer of the colon and rectum. Br J Surg 1976;63:13-189.
6. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M, Panish JF, Kurtz RC, Shike M, Ackroyd FW, Stewart ET, Skolnick M, Bishop DT, National Polyp Study Workgroup: Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996;334:82-87.
7. Negri E, Braga C, La Vecchia C, Franceschi S, Filiberti R, Montanella M, Falcini F, Conti E, Talamini R: Family history of cancer and risk of colorectal cancer in Italy. Br J Cancer 1998; 77:174-179.
8. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998; 48:6-29.
9. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-685.
10. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
11. Fearon EB, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990:61:759-767.
12. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66: 589-600.
13. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y: Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-665.
14. Lynch HT, Fitzgibbons R Jr, Chong S, Cavalieri J, Lynch J, Wallace F, Patel S: Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994;37:260-267.
15. Lynch HT, Fitzgibbons R Jr: Surgery, desmoid tumors and familial adenomatous polyposis: Case report and literature review. Am J Gastroenterol 1996;91:2598-2601.
16. Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, Slominski-Caster S, Cayouette MC, Priluck I, Luce MC: Attenuated familial adenomatous polyposis (AFAP): A phenotypically and genotypically distinctive variant of FAP. Cancer 1995;76:2427-2433.
17. Giardiello FM, Brensinger JD, Luce MC, Petersen GM, Cayouette MC, Krush AJ, Bacon JA, Booker SV, Bufill JA, Hamilton SR: Phenotypic expression of disease in families that have mutations in the 5′ region of the adenomatous polyposis coli gene. Ann Intern Med 1997;126: 514-519.
18. Giardello FM, Petersen GM, Piantadosi S, Gruber SB, Traboulsi EI, Offerhaus GJA, Muro K, Krush AJ, Booker SV, Luce MC, Laken SJ, Kinzler KW, Vogelstein B, Hamilton SR: APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 1997;40:521-525.
19. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-44.
20. Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RE, Skolnick MH: Dominant inheritance of adenomatous colonie polyps and colorectal cancer. N Engl J Med 1985;312:1540-1544.
21. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, Krush AJ, Yardley JH, Luk GD: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1511-1514.
22. Lynch HT, Smyrk T, Lynch J: Genetics and cancer of the gastrointestinal tract; in Wanebo HJ (ed): Surgery for Gastrointestinal Cancer: A Multidisciplinary Approach. Philadelphia, Lippincott-Raven Publishers, 1997, pp 59-86.
23. Jass JR, Williams CB, Bussey HJ, Morson BC: Juvenile polyposis: A precancerous condition. Histopathology 1988;13:619-630.
24. Warthin AS: Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-555.
25. Warthin AS: The further study of a cancer family. J Cancer Res 1925;9:279-286.
26. Warthin AS: Heredity of carcinoma in man. Ann Intern Med 1931;4:681-696.
27. Lynch HT, Krush AJ: Cancer family 'G' revisited: 1895-1970. Cancer 1971;27:1505-1511.
28. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ: Hereditary factors in cancer: Study of two large midwestern kindreds. Arch Intern Med 1966;117:206-212.
29. Itoh H, Houlston RS, Harocopos C, Slack J: Risk of cancer death in first-degree relatives of patients with hereditary nonpolyposis cancer syndrome (Lynch Type II): A study of 130 kindreds in the United Kingdom. Br J Surg 1990; 77:1367-1370.
30. Jass JR, Stewart SM, Schroeder D, Lane MR: Screening for hereditary nonpolyposis colorectal cancer in New Zealand. Eur J Gastroenterol Hepatol 1992;4:523-527.
31. Vasen HF, Hartog Jager FCA, Menko FH, Nagengast FM: Screening for hereditary nonpolyposis colorectal cancer: A study of 22 kindreds in the Netherlands. Am J Med 1989;86: 278-281.
32. Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L: Familial aggregation of tumors in the three year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344-4348.
33. Cristofaro G, Lynch HT, Caruso ML, Attolini A, DiMatteo G, Giorgio P, Senatore S, Argentieri A, Sbano E, Guanti G, Fusaro R, Giorgio I: New phenotypic aspects in a family with Lynch syndrome II. Cancer 1987;60:51-58.
34. Abusamra H, Maximova S, Bar-Meir S, Krispin M, Rotmensch HH: Cancer family syndrome of Lynch. Am J Med 1987;83:981-983.
35. Mecklin J-P, Jarvinen HJ, Peltokallio P: Cancer family syndrome: Genetic analysis of 22 Finnish kindreds. Gastroenterology 1986;30: 329-333.
36. Mecklin JP: Frequency of hereditary colorectal carcinoma. Gastroenterology 1987;93:1021-1025.
37. Boland CR, Troncale FJ: Familial colonie cancer without antecedent polyposis. Ann Intern Med 1984;100:700-701.
38. Lynch HT, Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review. Cancer 1996;78:1149-1167.
39. Lynch HT, Smyrk T, Lynch J: An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997;93:84-99.
40. Watson P, Lin K, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Lynch J, Thorson A, Lynch HT: Colorectal cancer survival in hereditary nonpolyposis colorectal cancer family members. Cancer, in press.
41. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF: Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 1985;113: 295-301.
42. Lynch HT, Lynch PM, Pester JA, Fusaro RM: Sebaceous neoplasia and visceral cancer (Torre's syndrome) and its relationship to the cancer family syndrome; in Lynch HT, Fusaro RM (eds): Cancer-associated Genodermaloses. New York, Van Nostrand Reinhold, 1982, pp 366-393.
43. Lynch HT, Fusaro RM: Muir-Torre syndrome: Heterogeneity, natural history, diagnosis, and management. Prob Gen Surg 1993;10:1-14.
44. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush A, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus GJA, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW: The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-847.
45. Peltomäki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Green LS, Jass JR, Weber JL, Leach FS, Petersen GM, Hamilton SR, de la Chapelle A, Vogelstein B: Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260: 810-812.
46. Lindblom A, Tannergard P, Werelius B, Nordenskjold M: Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer. Nature Genet 1993;5:279-282.
47. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A, Brogger A, Borresen A-L, de la Chapelle A: Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 1993;53: 5853-5855.
48. Strand M, Prolla TA, Liskay RM, Petes TD: Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993;365:274-276.
49. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins JA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-1038.
50. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan X-Y, Zhang J, Metzler PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-K, Jarvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-1225.
51. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-261.
52. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleishmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen M, Watson P, Lynch HT, Peltomaki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B: Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-1629.
53. Palombo F, Gillinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, Truong O, Hsuan JJ, Jiricny J: GTBP, a 160-kilodaltom protein essential for mismatch-binding activity in human cells. Science 1995;268:1912-1914.
54. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
55. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S: A National Cancer Institute workshop of hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997;89:1758-1762.
56. Vasen HFA, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard M-L, Mohr J, Fodde R, Khan PM: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110: 1020-1027.
57. Muir EG, Bell AJ, Barlow KA: Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg 1966;54:191-195.
58. Torre D: Multiple sebaceous tumors. Arch Dermatol 1968;98:549-551.
59. Lynch HT, Lynch PM, Pester J, Fusaro RM: The cancer family syndrome: Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med 1981;141:607-611.
60. Hall NR, Murday VA, Chapman P, Williams MAT, Burn J, Finan PJ, Bishop DT: Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 1994;30A:180-182.
61. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin J-P: Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-687.
62. Jass JR, Cottier DS, Pokos V, Parry S, Winship IM: Mixed epithelial polyps in association with hereditary non-polyposis eolorectal cancer providing an alternative pathway of cancer histogenesis. Pathology 1997;29:28-33.
63. Jass JR: Colorectal adenoma progression and genetic change: Is there a link? Ann Med 1995; 27:301-306.
64. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Click SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ: Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112: 594-642.
65. Jass JR: Familial cancer: Histopathological perspectives. J Clin Pathol 1997;50:892-895.
66. Jass JR, Stewart SM, Stewart J, Lane MR: Hereditary nonpolyposis colorectal cancer: Morphologies, genes and mutations. Mutation Res 1994;310:125-133.
67. Lynch HT, Albano W, Recabaren J, Lynch PM, Lynch JF, Elston R: Prolonged survical as a component of hereditary breast and nonpolyposis colon cancer. Med Hypoth 1981;7:1201-1209.
68. Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH, Lynch JF, Kimberling WJ: Natural history of hereditary cancer of the breast and colon. Cancer 1982;50: 360-363.
69. Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bülow S: Hereditary nonpolyposis colorectal cancer: Clinical features and survival: Results from the Danish HNPCC Register. Scand J Gastroenterol 1997;32:572-576.
70. Barth RJ Jr, Camp BJ, Martuscello TA, Dain BJ, Memoli VA: The cytokine microenvironment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Cancer 1996;78:1168-1178.
71. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma V-M: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997;182:318-324.
72. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-110.
73. Lynch HT, Cavalieri RJ, Lynch JF, Casey MJ: Gynecologic cancer clues to Lynch syndrome II diagnosis: A family report. Gynecol Oncol 1992;44:198-203.
74. Jäger AC, Bisgaard ML, Myrhoj T, Bernstein I, Rehfeld JF, Nielsen FC: Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet 1997; 61:129-138.
75. Rodriguez-Bigas MA, Vasen HFA, Pekka-Mecklin J, Myrhoj T, Rozen P, Bertario L, Järvinen HJ, Jass JR, Kunitomo K, Nomizu T, Driscoll DL, International Collaborative Group on HNPCC: Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. Ann Surg 1997;225: 202-207.
76. Lynch HT: Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 1996;39:109-110.
77. Church JM: Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med 1996;28:479-482.
78. Lynch HT, Fusaro RM, Lemon SJ, Smyrk T, Lynch J: Survey of cancer genetics: Genetic testing implications. Cancer 1997;80(suppl): 523-532.
79. Lynch HT, Thorson AG, Smyrk T: Rectal cancer after prolonged sulindac chemoprevention: A case report. Cancer 1995;75:936-938.
80. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, Coffey RJ Jr, Du Bois RN, Beauchamp RD: A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 1997;113:1883-1891.
81. Elder DJE, Paraskeva C: NSAIDs to prevent colorectal cancer: A question of sensitivity. Gastroenterology 1997:113:1999-2003.
82. Lynch HT, Smyrk T, Lynch J, Lanspa S, McGinn T, Cavalieri RJ: Genetic counseling in an extended attenuated familial adenomatous polyposis kindred. Am J Gastroenterol 1996; 91:455-459.